S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline
TEL AVIV, Israel, Sept. 04, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that S&P Global Ratings (“S&P”) has upgraded Teva’s long-term issuer credit rating to BBB- from BB+, with a Stable outlook. With this upgrade, along with the other recent upgrades from Fitch and Moody’s, Teva now has […]
Financial Post
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from Financial Post.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
Financial Post (financialpost.com), a Tier B publisher, filed this report on . CurrentWire published this page 28 minutes later, on .
Signal breakdown
CurrentWire ranked this story 53.6 of 100 in the snapshot this page was rendered from.
- Freshness
- 33.6 of 35
- Source authority
- 7 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 3.5 of 10
- Story prominence
- 5.5 of 10
- Velocity
- 0 of 5
Strongest signal: freshness, 33.6 of 35. How each signal is calculated.
Filed under World · International · Press release. Topics extracted from this report, with other live CurrentWire stories mentioning each: Global Ratings Upgrades Teva (none), Marking Third Credit Rating Upgrade (none), Recent Months (none), Reflecting Strong Execution (none), Financial Discipline (none).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.